Table 3 Relationship between TIMP-1 tumour cell immunoreactivity and treatment efficacy.
TIMP-1 expression | |||
|---|---|---|---|
Negative (n = 81) | Positive (n = 11) | p | |
Second look Response | 0.72 | ||
CR (n = 28) | 26 (32%) | 2 (18%) | |
PR (n = 48) | 42 (52%) | 6 (55%) | |
SD (n = 11) | 9 (11%) | 2 (18%) | |
PD (n = 5) | 4 (5%) | 1 (9%) | |